Sawai Pharma

Bora buys out generics manufacturer Upsher-Smith for $210M

Taiwan CDMO Bora is expanding its business in the United States, acquiring Minnesota generics manufacturer Upsher-Smith Laboratories for $210 million.

Kevin Dunleavy Jan 17, 2024 10:55am

FiercePharmaAsia—Legend Biotech, Chi-Med, Eisai

Jun 9, 2017 8:48am

Japan’s Sawai gets U.S. sites in Upsher-Smith generics deal

Jun 5, 2017 2:04pm